Petros Pharmaceuticals Inc Ordinary Shares PTPI
News
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance